nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—CYP2C8—Raloxifene—osteoporosis	0.173	0.298	CbGbCtD
Mometasone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.167	0.287	CbGbCtD
Mometasone—CYP2C8—Cholecalciferol—osteoporosis	0.134	0.23	CbGbCtD
Mometasone—CYP2C8—Estradiol—osteoporosis	0.108	0.185	CbGbCtD
Mometasone—Testolactone—CYP19A1—osteoporosis	0.00177	0.314	CrCbGaD
Mometasone—Fluoxymesterone—SHBG—osteoporosis	0.00122	0.215	CrCbGaD
Mometasone—Fluoxymesterone—ESR1—osteoporosis	0.000821	0.145	CrCbGaD
Mometasone—Hydrocortisone—SHBG—osteoporosis	0.000739	0.131	CrCbGaD
Mometasone—Back pain—Risedronate—osteoporosis	0.000706	0.00173	CcSEcCtD
Mometasone—Rhinitis—Conjugated Estrogens—osteoporosis	0.000703	0.00172	CcSEcCtD
Mometasone—Influenza—Estradiol—osteoporosis	0.000701	0.00172	CcSEcCtD
Mometasone—Asthma—Estradiol—osteoporosis	0.000701	0.00172	CcSEcCtD
Mometasone—Nausea—Ergocalciferol—osteoporosis	0.000696	0.0017	CcSEcCtD
Mometasone—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000696	0.0017	CcSEcCtD
Mometasone—Betamethasone—CYP19A1—osteoporosis	0.000695	0.123	CrCbGaD
Mometasone—Bronchospasm—Estradiol—osteoporosis	0.000689	0.00169	CcSEcCtD
Mometasone—Abdominal pain—Etidronic acid—osteoporosis	0.000689	0.00169	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000687	0.00168	CcSEcCtD
Mometasone—Angioedema—Ethinyl Estradiol—osteoporosis	0.000684	0.00167	CcSEcCtD
Mometasone—Paraesthesia—Estropipate—osteoporosis	0.000677	0.00166	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000676	0.00166	CcSEcCtD
Mometasone—Anorexia—Calcitriol—osteoporosis	0.000674	0.00165	CcSEcCtD
Mometasone—Bronchitis—Estradiol—osteoporosis	0.000674	0.00165	CcSEcCtD
Mometasone—Back pain—Pamidronate—osteoporosis	0.000671	0.00164	CcSEcCtD
Mometasone—Angioedema—Risedronate—osteoporosis	0.000667	0.00163	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000665	0.00163	CcSEcCtD
Mometasone—Dyspepsia—Estropipate—osteoporosis	0.000663	0.00162	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000659	0.00161	CcSEcCtD
Mometasone—Immune system disorder—Zoledronate—osteoporosis	0.000658	0.00161	CcSEcCtD
Mometasone—Mediastinal disorder—Zoledronate—osteoporosis	0.000656	0.00161	CcSEcCtD
Mometasone—Dyspepsia—Alendronate—osteoporosis	0.000653	0.0016	CcSEcCtD
Mometasone—Cough—Ethinyl Estradiol—osteoporosis	0.000653	0.0016	CcSEcCtD
Mometasone—Upper respiratory tract infection—Estradiol—osteoporosis	0.000651	0.00159	CcSEcCtD
Mometasone—Fatigue—Estropipate—osteoporosis	0.00065	0.00159	CcSEcCtD
Mometasone—Paraesthesia—Ibandronate—osteoporosis	0.000649	0.00159	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000645	0.00158	CcSEcCtD
Mometasone—Pain—Estropipate—osteoporosis	0.000645	0.00158	CcSEcCtD
Mometasone—Dyspepsia—Raloxifene—osteoporosis	0.000643	0.00157	CcSEcCtD
Mometasone—Cough—Risedronate—osteoporosis	0.000637	0.00156	CcSEcCtD
Mometasone—Dyspepsia—Ibandronate—osteoporosis	0.000636	0.00156	CcSEcCtD
Mometasone—Pain—Alendronate—osteoporosis	0.000635	0.00155	CcSEcCtD
Mometasone—Angioedema—Pamidronate—osteoporosis	0.000634	0.00155	CcSEcCtD
Mometasone—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000633	0.00155	CcSEcCtD
Mometasone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000632	0.00155	CcSEcCtD
Mometasone—Decreased appetite—Ibandronate—osteoporosis	0.000628	0.00154	CcSEcCtD
Mometasone—Pain—Raloxifene—osteoporosis	0.000624	0.00153	CcSEcCtD
Mometasone—Fatigue—Ibandronate—osteoporosis	0.000623	0.00153	CcSEcCtD
Mometasone—Chest pain—Risedronate—osteoporosis	0.000621	0.00152	CcSEcCtD
Mometasone—Myalgia—Risedronate—osteoporosis	0.000621	0.00152	CcSEcCtD
Mometasone—Arthralgia—Risedronate—osteoporosis	0.000621	0.00152	CcSEcCtD
Mometasone—Pain—Ibandronate—osteoporosis	0.000618	0.00151	CcSEcCtD
Mometasone—Pruritus—Etidronic acid—osteoporosis	0.000616	0.00151	CcSEcCtD
Mometasone—Gastrointestinal pain—Estropipate—osteoporosis	0.000616	0.00151	CcSEcCtD
Mometasone—Decreased appetite—Calcitriol—osteoporosis	0.000615	0.00151	CcSEcCtD
Mometasone—Back pain—Zoledronate—osteoporosis	0.000613	0.0015	CcSEcCtD
Mometasone—Dry mouth—Risedronate—osteoporosis	0.000608	0.00149	CcSEcCtD
Mometasone—Urinary tract infection—Estradiol—osteoporosis	0.000607	0.00149	CcSEcCtD
Mometasone—Conjunctivitis—Estradiol—osteoporosis	0.000607	0.00149	CcSEcCtD
Mometasone—Gastrointestinal pain—Alendronate—osteoporosis	0.000607	0.00149	CcSEcCtD
Mometasone—Infection—Ethinyl Estradiol—osteoporosis	0.000607	0.00149	CcSEcCtD
Mometasone—Cough—Pamidronate—osteoporosis	0.000605	0.00148	CcSEcCtD
Mometasone—Pain—Calcitriol—osteoporosis	0.000605	0.00148	CcSEcCtD
Mometasone—Gastrointestinal pain—Raloxifene—osteoporosis	0.000597	0.00146	CcSEcCtD
Mometasone—Diarrhoea—Etidronic acid—osteoporosis	0.000596	0.00146	CcSEcCtD
Mometasone—Abdominal pain—Estropipate—osteoporosis	0.000596	0.00146	CcSEcCtD
Mometasone—Body temperature increased—Estropipate—osteoporosis	0.000596	0.00146	CcSEcCtD
Mometasone—Infection—Risedronate—osteoporosis	0.000592	0.00145	CcSEcCtD
Mometasone—Gastrointestinal pain—Ibandronate—osteoporosis	0.000591	0.00145	CcSEcCtD
Mometasone—Arthralgia—Pamidronate—osteoporosis	0.000591	0.00145	CcSEcCtD
Mometasone—Myalgia—Pamidronate—osteoporosis	0.000591	0.00145	CcSEcCtD
Mometasone—Back pain—Conjugated Estrogens—osteoporosis	0.00059	0.00144	CcSEcCtD
Mometasone—Epistaxis—Estradiol—osteoporosis	0.000589	0.00144	CcSEcCtD
Mometasone—Abdominal pain—Alendronate—osteoporosis	0.000587	0.00144	CcSEcCtD
Mometasone—Body temperature increased—Alendronate—osteoporosis	0.000587	0.00144	CcSEcCtD
Mometasone—Sinusitis—Estradiol—osteoporosis	0.000586	0.00144	CcSEcCtD
Mometasone—Angioedema—Zoledronate—osteoporosis	0.000579	0.00142	CcSEcCtD
Mometasone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000579	0.00142	CcSEcCtD
Mometasone—Abdominal pain—Raloxifene—osteoporosis	0.000577	0.00141	CcSEcCtD
Mometasone—Body temperature increased—Raloxifene—osteoporosis	0.000577	0.00141	CcSEcCtD
Mometasone—Body temperature increased—Ibandronate—osteoporosis	0.000571	0.0014	CcSEcCtD
Mometasone—Abdominal pain—Ibandronate—osteoporosis	0.000571	0.0014	CcSEcCtD
Mometasone—Anaphylactic shock—Pamidronate—osteoporosis	0.000566	0.00139	CcSEcCtD
Mometasone—Infection—Pamidronate—osteoporosis	0.000563	0.00138	CcSEcCtD
Mometasone—Rhinitis—Estradiol—osteoporosis	0.000562	0.00138	CcSEcCtD
Mometasone—Abdominal pain—Calcitriol—osteoporosis	0.000559	0.00137	CcSEcCtD
Mometasone—Body temperature increased—Calcitriol—osteoporosis	0.000559	0.00137	CcSEcCtD
Mometasone—Angioedema—Conjugated Estrogens—osteoporosis	0.000558	0.00136	CcSEcCtD
Mometasone—Pharyngitis—Estradiol—osteoporosis	0.000557	0.00136	CcSEcCtD
Mometasone—Vomiting—Etidronic acid—osteoporosis	0.000554	0.00136	CcSEcCtD
Mometasone—Cough—Zoledronate—osteoporosis	0.000553	0.00135	CcSEcCtD
Mometasone—Rash—Etidronic acid—osteoporosis	0.000549	0.00134	CcSEcCtD
Mometasone—Dermatitis—Etidronic acid—osteoporosis	0.000549	0.00134	CcSEcCtD
Mometasone—Headache—Etidronic acid—osteoporosis	0.000546	0.00134	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000543	0.00133	CcSEcCtD
Mometasone—Asthenia—Estropipate—osteoporosis	0.000541	0.00132	CcSEcCtD
Mometasone—Anorexia—Pamidronate—osteoporosis	0.00054	0.00132	CcSEcCtD
Mometasone—Chest pain—Zoledronate—osteoporosis	0.00054	0.00132	CcSEcCtD
Mometasone—Arthralgia—Zoledronate—osteoporosis	0.00054	0.00132	CcSEcCtD
Mometasone—Myalgia—Zoledronate—osteoporosis	0.00054	0.00132	CcSEcCtD
Mometasone—Paraesthesia—Risedronate—osteoporosis	0.000535	0.00131	CcSEcCtD
Mometasone—Pruritus—Estropipate—osteoporosis	0.000533	0.00131	CcSEcCtD
Mometasone—Asthenia—Alendronate—osteoporosis	0.000533	0.0013	CcSEcCtD
Mometasone—Cough—Conjugated Estrogens—osteoporosis	0.000533	0.0013	CcSEcCtD
Mometasone—Dyspnoea—Risedronate—osteoporosis	0.000531	0.0013	CcSEcCtD
Mometasone—Dry mouth—Zoledronate—osteoporosis	0.000528	0.00129	CcSEcCtD
Mometasone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000527	0.00129	CcSEcCtD
Mometasone—Pruritus—Alendronate—osteoporosis	0.000525	0.00129	CcSEcCtD
Mometasone—Dyspepsia—Risedronate—osteoporosis	0.000524	0.00128	CcSEcCtD
Mometasone—Arthralgia—Conjugated Estrogens—osteoporosis	0.00052	0.00127	CcSEcCtD
Mometasone—Myalgia—Conjugated Estrogens—osteoporosis	0.00052	0.00127	CcSEcCtD
Mometasone—Chest pain—Conjugated Estrogens—osteoporosis	0.00052	0.00127	CcSEcCtD
Mometasone—Asthenia—Ibandronate—osteoporosis	0.000519	0.00127	CcSEcCtD
Mometasone—Nausea—Etidronic acid—osteoporosis	0.000518	0.00127	CcSEcCtD
Mometasone—Anaphylactic shock—Zoledronate—osteoporosis	0.000517	0.00127	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000516	0.00126	CcSEcCtD
Mometasone—Diarrhoea—Estropipate—osteoporosis	0.000516	0.00126	CcSEcCtD
Mometasone—Infection—Zoledronate—osteoporosis	0.000514	0.00126	CcSEcCtD
Mometasone—Fatigue—Risedronate—osteoporosis	0.000514	0.00126	CcSEcCtD
Mometasone—Pruritus—Ibandronate—osteoporosis	0.000511	0.00125	CcSEcCtD
Mometasone—Pain—Risedronate—osteoporosis	0.000509	0.00125	CcSEcCtD
Mometasone—Paraesthesia—Pamidronate—osteoporosis	0.000508	0.00124	CcSEcCtD
Mometasone—Diarrhoea—Alendronate—osteoporosis	0.000508	0.00124	CcSEcCtD
Mometasone—Asthenia—Calcitriol—osteoporosis	0.000508	0.00124	CcSEcCtD
Mometasone—Immune system disorder—Estradiol—osteoporosis	0.000507	0.00124	CcSEcCtD
Mometasone—Mediastinal disorder—Estradiol—osteoporosis	0.000506	0.00124	CcSEcCtD
Mometasone—Dyspnoea—Pamidronate—osteoporosis	0.000505	0.00124	CcSEcCtD
Mometasone—Pruritus—Calcitriol—osteoporosis	0.000501	0.00123	CcSEcCtD
Mometasone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.0005	0.00122	CcSEcCtD
Mometasone—Diarrhoea—Raloxifene—osteoporosis	0.0005	0.00122	CcSEcCtD
Mometasone—Dyspepsia—Pamidronate—osteoporosis	0.000498	0.00122	CcSEcCtD
Mometasone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000498	0.00122	CcSEcCtD
Mometasone—Infection—Conjugated Estrogens—osteoporosis	0.000495	0.00121	CcSEcCtD
Mometasone—Diarrhoea—Ibandronate—osteoporosis	0.000495	0.00121	CcSEcCtD
Mometasone—Anorexia—Zoledronate—osteoporosis	0.000493	0.00121	CcSEcCtD
Mometasone—Decreased appetite—Pamidronate—osteoporosis	0.000492	0.0012	CcSEcCtD
Mometasone—Fatigue—Pamidronate—osteoporosis	0.000488	0.00119	CcSEcCtD
Mometasone—Gastrointestinal pain—Risedronate—osteoporosis	0.000487	0.00119	CcSEcCtD
Mometasone—Pain—Pamidronate—osteoporosis	0.000484	0.00119	CcSEcCtD
Mometasone—Diarrhoea—Calcitriol—osteoporosis	0.000484	0.00118	CcSEcCtD
Mometasone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000483	0.00118	CcSEcCtD
Mometasone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000483	0.00118	CcSEcCtD
Mometasone—Vomiting—Estropipate—osteoporosis	0.000479	0.00117	CcSEcCtD
Mometasone—Rash—Estropipate—osteoporosis	0.000475	0.00116	CcSEcCtD
Mometasone—Dermatitis—Estropipate—osteoporosis	0.000475	0.00116	CcSEcCtD
Mometasone—Anorexia—Conjugated Estrogens—osteoporosis	0.000475	0.00116	CcSEcCtD
Mometasone—Back pain—Estradiol—osteoporosis	0.000472	0.00116	CcSEcCtD
Mometasone—Headache—Estropipate—osteoporosis	0.000472	0.00116	CcSEcCtD
Mometasone—Vomiting—Alendronate—osteoporosis	0.000472	0.00116	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000471	0.00115	CcSEcCtD
Mometasone—Abdominal pain—Risedronate—osteoporosis	0.000471	0.00115	CcSEcCtD
Mometasone—Body temperature increased—Risedronate—osteoporosis	0.000471	0.00115	CcSEcCtD
Mometasone—Rash—Alendronate—osteoporosis	0.000468	0.00115	CcSEcCtD
Mometasone—Dermatitis—Alendronate—osteoporosis	0.000468	0.00114	CcSEcCtD
Mometasone—Headache—Alendronate—osteoporosis	0.000465	0.00114	CcSEcCtD
Mometasone—Paraesthesia—Zoledronate—osteoporosis	0.000464	0.00114	CcSEcCtD
Mometasone—Vomiting—Raloxifene—osteoporosis	0.000464	0.00114	CcSEcCtD
Mometasone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000463	0.00113	CcSEcCtD
Mometasone—Dyspnoea—Zoledronate—osteoporosis	0.000461	0.00113	CcSEcCtD
Mometasone—Rash—Raloxifene—osteoporosis	0.00046	0.00113	CcSEcCtD
Mometasone—Dermatitis—Raloxifene—osteoporosis	0.00046	0.00113	CcSEcCtD
Mometasone—Vomiting—Ibandronate—osteoporosis	0.00046	0.00112	CcSEcCtD
Mometasone—Headache—Raloxifene—osteoporosis	0.000457	0.00112	CcSEcCtD
Mometasone—Rash—Ibandronate—osteoporosis	0.000456	0.00112	CcSEcCtD
Mometasone—Dermatitis—Ibandronate—osteoporosis	0.000455	0.00111	CcSEcCtD
Mometasone—Dyspepsia—Zoledronate—osteoporosis	0.000455	0.00111	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000454	0.00111	CcSEcCtD
Mometasone—Headache—Ibandronate—osteoporosis	0.000453	0.00111	CcSEcCtD
Mometasone—Vomiting—Calcitriol—osteoporosis	0.00045	0.0011	CcSEcCtD
Mometasone—Decreased appetite—Zoledronate—osteoporosis	0.00045	0.0011	CcSEcCtD
Mometasone—Nausea—Estropipate—osteoporosis	0.000448	0.0011	CcSEcCtD
Mometasone—Abdominal pain—Pamidronate—osteoporosis	0.000448	0.0011	CcSEcCtD
Mometasone—Body temperature increased—Pamidronate—osteoporosis	0.000448	0.0011	CcSEcCtD
Mometasone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000447	0.00109	CcSEcCtD
Mometasone—Angioedema—Estradiol—osteoporosis	0.000446	0.00109	CcSEcCtD
Mometasone—Rash—Calcitriol—osteoporosis	0.000446	0.00109	CcSEcCtD
Mometasone—Fatigue—Zoledronate—osteoporosis	0.000446	0.00109	CcSEcCtD
Mometasone—Dermatitis—Calcitriol—osteoporosis	0.000446	0.00109	CcSEcCtD
Mometasone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000444	0.00109	CcSEcCtD
Mometasone—Headache—Calcitriol—osteoporosis	0.000443	0.00108	CcSEcCtD
Mometasone—Pain—Zoledronate—osteoporosis	0.000442	0.00108	CcSEcCtD
Mometasone—Nausea—Alendronate—osteoporosis	0.000441	0.00108	CcSEcCtD
Mometasone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000438	0.00107	CcSEcCtD
Mometasone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000438	0.00107	CcSEcCtD
Mometasone—Nausea—Raloxifene—osteoporosis	0.000434	0.00106	CcSEcCtD
Mometasone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000433	0.00106	CcSEcCtD
Mometasone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000432	0.00106	CcSEcCtD
Mometasone—Fatigue—Conjugated Estrogens—osteoporosis	0.000429	0.00105	CcSEcCtD
Mometasone—Nausea—Ibandronate—osteoporosis	0.000429	0.00105	CcSEcCtD
Mometasone—Asthenia—Risedronate—osteoporosis	0.000427	0.00105	CcSEcCtD
Mometasone—Cough—Estradiol—osteoporosis	0.000426	0.00104	CcSEcCtD
Mometasone—Pain—Conjugated Estrogens—osteoporosis	0.000426	0.00104	CcSEcCtD
Mometasone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000423	0.00104	CcSEcCtD
Mometasone—Pruritus—Risedronate—osteoporosis	0.000421	0.00103	CcSEcCtD
Mometasone—Nausea—Calcitriol—osteoporosis	0.00042	0.00103	CcSEcCtD
Mometasone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000418	0.00102	CcSEcCtD
Mometasone—Arthralgia—Estradiol—osteoporosis	0.000416	0.00102	CcSEcCtD
Mometasone—Myalgia—Estradiol—osteoporosis	0.000416	0.00102	CcSEcCtD
Mometasone—Chest pain—Estradiol—osteoporosis	0.000416	0.00102	CcSEcCtD
Mometasone—Abdominal pain—Zoledronate—osteoporosis	0.000409	0.001	CcSEcCtD
Mometasone—Body temperature increased—Zoledronate—osteoporosis	0.000409	0.001	CcSEcCtD
Mometasone—Diarrhoea—Risedronate—osteoporosis	0.000408	0.000997	CcSEcCtD
Mometasone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000407	0.000997	CcSEcCtD
Mometasone—Dry mouth—Estradiol—osteoporosis	0.000407	0.000995	CcSEcCtD
Mometasone—Asthenia—Pamidronate—osteoporosis	0.000406	0.000994	CcSEcCtD
Mometasone—Dexamethasone—CYP19A1—osteoporosis	0.000404	0.0716	CrCbGaD
Mometasone—Pruritus—Pamidronate—osteoporosis	0.000401	0.00098	CcSEcCtD
Mometasone—Anaphylactic shock—Estradiol—osteoporosis	0.000399	0.000976	CcSEcCtD
Mometasone—Infection—Estradiol—osteoporosis	0.000396	0.000969	CcSEcCtD
Mometasone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000394	0.000964	CcSEcCtD
Mometasone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000394	0.000964	CcSEcCtD
Mometasone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000388	0.000951	CcSEcCtD
Mometasone—Diarrhoea—Pamidronate—osteoporosis	0.000387	0.000948	CcSEcCtD
Mometasone—Rash—Ethinyl Estradiol—osteoporosis	0.000385	0.000943	CcSEcCtD
Mometasone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000385	0.000942	CcSEcCtD
Mometasone—Headache—Ethinyl Estradiol—osteoporosis	0.000383	0.000937	CcSEcCtD
Mometasone—Vomiting—Risedronate—osteoporosis	0.000379	0.000927	CcSEcCtD
Mometasone—Rash—Risedronate—osteoporosis	0.000376	0.000919	CcSEcCtD
Mometasone—Dermatitis—Risedronate—osteoporosis	0.000375	0.000918	CcSEcCtD
Mometasone—Headache—Risedronate—osteoporosis	0.000373	0.000913	CcSEcCtD
Mometasone—Asthenia—Zoledronate—osteoporosis	0.000371	0.000908	CcSEcCtD
Mometasone—Pruritus—Zoledronate—osteoporosis	0.000366	0.000896	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000363	0.000889	CcSEcCtD
Mometasone—Nausea—Ethinyl Estradiol—osteoporosis	0.000363	0.000888	CcSEcCtD
Mometasone—Vomiting—Pamidronate—osteoporosis	0.00036	0.000881	CcSEcCtD
Mometasone—Paraesthesia—Estradiol—osteoporosis	0.000358	0.000876	CcSEcCtD
Mometasone—Asthenia—Conjugated Estrogens—osteoporosis	0.000357	0.000875	CcSEcCtD
Mometasone—Rash—Pamidronate—osteoporosis	0.000357	0.000874	CcSEcCtD
Mometasone—Dermatitis—Pamidronate—osteoporosis	0.000357	0.000873	CcSEcCtD
Mometasone—Dyspnoea—Estradiol—osteoporosis	0.000355	0.00087	CcSEcCtD
Mometasone—Headache—Pamidronate—osteoporosis	0.000355	0.000868	CcSEcCtD
Mometasone—Diarrhoea—Zoledronate—osteoporosis	0.000354	0.000866	CcSEcCtD
Mometasone—Nausea—Risedronate—osteoporosis	0.000354	0.000866	CcSEcCtD
Mometasone—Pruritus—Conjugated Estrogens—osteoporosis	0.000352	0.000862	CcSEcCtD
Mometasone—Dyspepsia—Estradiol—osteoporosis	0.000351	0.000859	CcSEcCtD
Mometasone—Decreased appetite—Estradiol—osteoporosis	0.000346	0.000848	CcSEcCtD
Mometasone—Fatigue—Estradiol—osteoporosis	0.000344	0.000841	CcSEcCtD
Mometasone—Pain—Estradiol—osteoporosis	0.000341	0.000834	CcSEcCtD
Mometasone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000341	0.000834	CcSEcCtD
Mometasone—Nausea—Pamidronate—osteoporosis	0.000336	0.000823	CcSEcCtD
Mometasone—Vomiting—Zoledronate—osteoporosis	0.000329	0.000805	CcSEcCtD
Mometasone—Rash—Zoledronate—osteoporosis	0.000326	0.000798	CcSEcCtD
Mometasone—Gastrointestinal pain—Estradiol—osteoporosis	0.000326	0.000798	CcSEcCtD
Mometasone—Dermatitis—Zoledronate—osteoporosis	0.000326	0.000797	CcSEcCtD
Mometasone—Headache—Zoledronate—osteoporosis	0.000324	0.000793	CcSEcCtD
Mometasone—Vomiting—Conjugated Estrogens—osteoporosis	0.000317	0.000775	CcSEcCtD
Mometasone—Abdominal pain—Estradiol—osteoporosis	0.000315	0.000771	CcSEcCtD
Mometasone—Body temperature increased—Estradiol—osteoporosis	0.000315	0.000771	CcSEcCtD
Mometasone—Rash—Conjugated Estrogens—osteoporosis	0.000314	0.000769	CcSEcCtD
Mometasone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000314	0.000768	CcSEcCtD
Mometasone—Headache—Conjugated Estrogens—osteoporosis	0.000312	0.000764	CcSEcCtD
Mometasone—Nausea—Zoledronate—osteoporosis	0.000307	0.000752	CcSEcCtD
Mometasone—Nausea—Conjugated Estrogens—osteoporosis	0.000296	0.000724	CcSEcCtD
Mometasone—Asthenia—Estradiol—osteoporosis	0.000286	0.0007	CcSEcCtD
Mometasone—Pruritus—Estradiol—osteoporosis	0.000282	0.00069	CcSEcCtD
Mometasone—Diarrhoea—Estradiol—osteoporosis	0.000273	0.000667	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00027	0.0735	CbGpPWpGaD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000268	0.0729	CbGpPWpGaD
Mometasone—Vomiting—Estradiol—osteoporosis	0.000253	0.00062	CcSEcCtD
Mometasone—Rash—Estradiol—osteoporosis	0.000251	0.000615	CcSEcCtD
Mometasone—Dermatitis—Estradiol—osteoporosis	0.000251	0.000615	CcSEcCtD
Mometasone—Headache—Estradiol—osteoporosis	0.00025	0.000611	CcSEcCtD
Mometasone—Nausea—Estradiol—osteoporosis	0.000237	0.000579	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000111	0.0302	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.00011	0.0301	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000109	0.0296	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	9.76e-05	0.0266	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	9.68e-05	0.0264	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	9.42e-05	0.0257	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	9.28e-05	0.0253	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—VDR—osteoporosis	8.76e-05	0.0239	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	8.72e-05	0.0237	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	8.69e-05	0.0237	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	8.21e-05	0.0224	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	8.17e-05	0.0223	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	8.16e-05	0.0222	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	8.05e-05	0.0219	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	7.45e-05	0.0203	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	6.92e-05	0.0188	CbGpPWpGaD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	6.69e-05	0.0182	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	6.69e-05	0.0182	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.62e-05	0.018	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—WNT1—osteoporosis	5.4e-05	0.0147	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	5.29e-05	0.0144	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	5.14e-05	0.014	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	5.02e-05	0.0137	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—BMP2—osteoporosis	4.89e-05	0.0133	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	4.78e-05	0.013	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.29e-05	0.0117	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.23e-05	0.0115	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	4.1e-05	0.0112	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	4.05e-05	0.011	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	4.04e-05	0.011	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	3.65e-05	0.00995	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	3.56e-05	0.00971	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	3.51e-05	0.00957	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.48e-05	0.00947	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	3.47e-05	0.00944	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	3.25e-05	0.00886	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IRS2—osteoporosis	2.68e-05	0.00729	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LEP—osteoporosis	2.62e-05	0.00714	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.58e-05	0.00702	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.35e-05	0.0064	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IRS1—osteoporosis	2.34e-05	0.00637	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.23e-05	0.00607	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	2.18e-05	0.00594	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—osteoporosis	2.16e-05	0.0059	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	2.13e-05	0.00582	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	2.13e-05	0.0058	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.09e-05	0.00569	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	1.9e-05	0.00517	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.9e-05	0.00517	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—U2AF1—osteoporosis	1.89e-05	0.00515	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	1.85e-05	0.00503	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	1.82e-05	0.00496	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.73e-05	0.00472	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.69e-05	0.0046	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	1.6e-05	0.00437	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.51e-05	0.0041	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.44e-05	0.00393	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.41e-05	0.00385	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPL24—osteoporosis	1.41e-05	0.00383	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.35e-05	0.00368	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.3e-05	0.00354	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—osteoporosis	1.21e-05	0.0033	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.2e-05	0.00326	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.15e-05	0.00313	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—POMC—osteoporosis	1.11e-05	0.00302	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.05e-05	0.00285	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FDPS—osteoporosis	1.05e-05	0.00285	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PKM—osteoporosis	1.05e-05	0.00285	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPD2—osteoporosis	9.92e-06	0.0027	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PGLS—osteoporosis	9.92e-06	0.0027	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—osteoporosis	9.78e-06	0.00266	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	9.13e-06	0.00249	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ATIC—osteoporosis	9.07e-06	0.00247	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PNP—osteoporosis	9.07e-06	0.00247	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	8.45e-06	0.0023	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMA5—osteoporosis	8.12e-06	0.00221	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMA2—osteoporosis	8.12e-06	0.00221	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—OXCT1—osteoporosis	7.71e-06	0.0021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA2—osteoporosis	7.71e-06	0.0021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MGLL—osteoporosis	7.52e-06	0.00205	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR2—osteoporosis	7.25e-06	0.00197	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.09e-06	0.00193	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—IDH2—osteoporosis	6.39e-06	0.00174	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP27A1—osteoporosis	6.01e-06	0.00164	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACP5—osteoporosis	5.85e-06	0.00159	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.77e-06	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—VDR—osteoporosis	5.75e-06	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TPI1—osteoporosis	5.44e-06	0.00148	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—P4HB—osteoporosis	5.11e-06	0.00139	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GAPDH—osteoporosis	5.02e-06	0.00137	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RAP1A—osteoporosis	4.89e-06	0.00133	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	4.75e-06	0.00129	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—osteoporosis	4.4e-06	0.0012	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.26e-06	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO1—osteoporosis	3.95e-06	0.00108	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMA5—osteoporosis	3.89e-06	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMA2—osteoporosis	3.89e-06	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP19A1—osteoporosis	3.16e-06	0.00086	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADCY5—osteoporosis	2.58e-06	0.000703	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPX1—osteoporosis	2.57e-06	0.0007	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—osteoporosis	2.37e-06	0.000646	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—osteoporosis	2.29e-06	0.000623	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—POMC—osteoporosis	1.9e-06	0.000517	CbGpPWpGaD
